Clariane Shares Drop 2.3% and Fall Below Key Moving Averages
Clariane fell by 2.3% this Wednesday, March 11, to 3.83 euros, amid a widespread decline in European stock markets. The stock is now trading below its 20-day and 50-day moving averages, both positioned at 3.89 euros. BNP Paribas Exane has recently adjusted its price target on the stock.
Current Trading Session
During the session, Clariane is trading at 3.83 euros, down 2.3% from the previous close of 3.92 euros. The stock has thus fallen below its 20-day and 50-day moving averages, both at 3.89 euros, indicating a weakening of the short-term upward momentum. The price is also approaching the support threshold at 3.74 euros; a downward breach of this level could increase selling pressure. The Relative Strength Index (RSI), which measures the relative strength of the ongoing movement, stands at 45, indicating a neutral zone but with a downward orientation. This level does not signal an oversold condition but confirms the lack of buying support at this stage. It is worth noting that the nearest resistance is at 4.07 euros, a level the stock has recently failed to surpass. This decline is part of a challenging session for European markets: the CAC 40 is down 0.49%, while the DAX has lost 0.94% and the FTSE 100 is down 0.81%. The SBF 120, which includes Clariane, is down 0.52%.
Recent Analyst Adjustment
On March 9, BNP Paribas Exane lowered its price target on Clariane from 4.90 euros to 4.70 euros, while maintaining an 'outperform' rating. At the current price of 3.83 euros, this target implies a potential revaluation of about 22.7%. Over the past year, the stock has still posted an increase of 8.01%, despite a slight decline of 0.98% over the last seven days. The quarterly performance remains almost stable at +0.52%. Upcoming financial milestones likely to provide new insights include the publication of the first quarter 2026 revenue, scheduled for April 23, followed by the annual general meeting planned for May 12.
